Tariff threats and trade restrictions are the latest irritations in rising U.S/China tensions. But the Chartmaster Carter Worth says now could be the time to get in. What he’s seeing in the technicals, and how your money can fare in the China trade. Plus Fast Money’s special coverage of the weight loss drug space continues. How one biotech company is standing out from the competition, and how its obesity drug could do more than trim your waistline.

Fast Money Disclaimer